Since I’ve received so many positive reader emails about my first installment on biotech investing, I’ve put together another list of biotech companies that are expected to report major upcoming catalysts in the form of clinical trial data and FDA decisions. Just as I did before, I have put together a list of companies that are expected to be on the move within the next nine months and have a market cap ranging from around $100 million to just beyond $1 billion. Let’s get right to it.>>> Discuss This Story
